These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34750100)

  • 21. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
    Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
    [No Abstract]   [Full Text] [Related]  

  • 22. Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.
    Khojasteh H; Riazi-Esfahani H; Khalili Pour E; Faghihi H; Ghassemi F; Bazvand F; Mahmoudzadeh R; Salabati M; Mirghorbani M; Riazi Esfahani M
    Int Ophthalmol; 2020 Mar; 40(3):571-581. PubMed ID: 31712927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema.
    Chatziralli I; Dimitriou E; Lambadiari V; Kazantzis D; Kapsis P; Theodossiadis G; Theodossiadis P; Sergentanis TN
    Semin Ophthalmol; 2022 Jul; 37(5):668-675. PubMed ID: 35468026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
    Lee J; Moon BG; Cho AR; Yoon YH
    Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy.
    Borrelli E; Grosso D; Barresi C; Lari G; Sacconi R; Senni C; Querques L; Bandello F; Querques G
    Am J Ophthalmol; 2022 Mar; 235():80-89. PubMed ID: 34509431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study.
    Granstam E; Rosenblad A; Modher Raghib A; Granström T; Eriksson JW; Lindholm Olinder A; Leksell J
    Acta Ophthalmol; 2020 Jun; 98(4):360-367. PubMed ID: 31656056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
    Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
    Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
    Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
    Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography.
    Mao J; Zhang S; Zheng Z; Deng X; Liu C; Chen Y; Zhao S; Zhang Y; Shen L
    Acta Ophthalmol; 2022 Jun; 100(4):e891-e898. PubMed ID: 34403203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema.
    Rana V; Agarwal A; Arora A; Bansal R; Dogra M; Bhadada SK; Singh N; Gupta V
    Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S16-S21. PubMed ID: 38131536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema.
    Velaga SB; Nittala MG; Alagorie AR; Marram J; Hu ZJ; Wang Z; Ciulla TA; Kapik B; Sadda SR; Ip M
    Can J Ophthalmol; 2024 Apr; 59(2):109-118. PubMed ID: 36803932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema.
    De S; Saxena S; Kaur A; Mahdi AA; Misra A; Singh M; Meyer CH; Akduman L
    Eye (Lond); 2021 May; 35(5):1490-1495. PubMed ID: 32690922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
    Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Disorganization of Retinal Inner Layers With Visual Acuity In Eyes With Uveitic Cystoid Macular Edema.
    Grewal DS; O'Sullivan ML; Kron M; Jaffe GJ
    Am J Ophthalmol; 2017 May; 177():116-125. PubMed ID: 28237411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
    Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
    Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
    Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
    Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.